New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Lantern Pharma Inc.
LTRN
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

36M

Biotechnology

Next Earning date - 13 Nov 2024

36M

Biotechnology

Next Earning date - 13 Nov 2024

3.34USD
Shape0.02 ( 0.60%)
favorite-chart

Relative Strenght

85
favorite-chart

Volume Buzz

-32%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

72%

Quote Panel

Shape
Updated October 27, 2024
1W -0.60 % 1M -8.99 % 3M -27.55 % 1Y 28.46 %

Key Metrics

Shape
  • Market Cap

    35.95M


  • Shares Outstanding

    10.76M


  • Share in Float

    8.02M


  • Dividende

    0


  • Earning Date

    13 Nov 2024


  • Price Target

    3.34


  • Average Volume

    46557


  • Beta

    1.546


  • Range

    2.38-11.99


  • Industry

    Biotechnology


  • Website

    https://www.lanternpharma.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

137.73x

P/S Ratio

1.16x

P/B Ratio

0.0

Debt/Equity

-6798.5%

Net Margin

$-1.6

EPS

How LTRN compares to sector?

P/E Ratio

Relative Strength

Shape

LTRN

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape
0

$1.92

Shape-317%

2025-EPS

0

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.21
vs -0.36

Q4.22

arrow
arrow

N/A

-0.31
vs -0.31

Q1.23

arrow
arrow

N/A

-0.36
vs -0.38

Q2.23

arrow
arrow

N/A

-0.44
vs -0.41

Q3.23

arrow
arrow

N/A

-0.29
vs -0.21

Q4.23

arrow
arrow

N/A

-0.39
vs -0.31

Q1.24

arrow
arrow

N/A

-0.51
vs -0.36

Q2.24

arrow
arrow

N/A

-0.46
vs -0.44

Q3.24

arrow
arrow

N/A

-0.56
vs -0.29

Q4.24

arrow
arrow

N/A

-0.59
vs -0.39

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

NA

NA  vs NA

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

261.1K  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-4%

-0.04
vs -0.08

Q4.22

arrow
arrow

-5%

-0.05
vs -0.04

Q1.23

arrow
arrow

-7%

-0.07
vs -0.05

Q2.23

arrow
arrow

-10%

-0.10
vs -0.07

Q3.23

arrow
arrow

-7%

-0.07
vs -0.10

Q4.23

arrow
arrow

-10%

-0.10
vs -0.07

Q1.24

arrow
arrow

-15%

-0.15
vs -0.10

Q2.24

arrow
arrow

-16%

-0.16
vs -0.15

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

27

27
vs 26

4%

Q4.22

arrow
arrow

24

24
vs 27

-11%

Q1.23

arrow
arrow

22

22
vs 24

-8%

Q2.23

arrow
arrow

26

26
vs 22

18%

Q3.23

arrow
arrow

27

27
vs 26

4%

Q4.23

arrow
arrow

30

30
vs 27

11%

Q1.24

arrow
arrow

37

37
vs 30

23%

Q2.24

arrow
arrow

41

41
vs 37

11%

Earnings Growth

Latest News